UMB Bank n.a. Buys 346 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

UMB Bank n.a. boosted its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 41.7% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,176 shares of the company’s stock after acquiring an additional 346 shares during the quarter. UMB Bank n.a.’s holdings in Option Care Health were worth $27,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. GAMMA Investing LLC grew its position in shares of Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. lifted its holdings in shares of Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after purchasing an additional 1,446 shares during the period. International Assets Investment Management LLC grew its position in shares of Option Care Health by 3,029.7% in the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after buying an additional 2,757 shares during the last quarter. Quarry LP boosted its stake in shares of Option Care Health by 327.7% in the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after purchasing an additional 2,628 shares during the last quarter. Finally, Blue Trust Inc. grew its holdings in Option Care Health by 37.2% during the 3rd quarter. Blue Trust Inc. now owns 4,022 shares of the company’s stock worth $126,000 after acquiring an additional 1,091 shares during the period. 98.05% of the stock is owned by institutional investors.

Option Care Health Stock Up 1.1 %

Shares of NASDAQ:OPCH opened at $30.33 on Monday. The stock’s 50-day moving average price is $24.42 and its 200-day moving average price is $27.83. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $34.63. The stock has a market capitalization of $5.16 billion, a P/E ratio of 25.49, a price-to-earnings-growth ratio of 2.11 and a beta of 1.31.

Insider Activity

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of Option Care Health stock in a transaction that occurred on Friday, November 8th. The shares were bought at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.64% of the company’s stock.

Analyst Ratings Changes

OPCH has been the topic of several research analyst reports. Truist Financial cut their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and upped their target price for the company from $26.00 to $33.00 in a report on Monday, January 13th. Barrington Research increased their target price on shares of Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a research report on Tuesday, January 14th. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and increased their target price for the stock from $26.00 to $35.00 in a research report on Thursday. Finally, The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $32.25.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.